Pharmasense SRL
Pharmasense reported total assets of €1.93m at the end of the 2025 financial year (annual accounts filed with the NBB on 28 Aug 2026).
The score of Pharmasense shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity +28 % Total assets -2 %
Accounts of the company itself (not consolidated).
The full file covers 10 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Pharmasense's annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 28 Aug 2026
- Year ended 31 Dec 2024filed on 26 Aug 2025
- Year ended 31 Dec 2023filed on 21 Aug 2024
- Year ended 31 Dec 2022filed on 31 Aug 2023
- Year ended 31 Dec 2021filed on 22 Jun 2022
Pharmasense's financial analysis
- Solvency65.1%sector median: 55.6%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Pharmasense
Pharmasense's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0827.039.024
- VAT number
- BE0827039024
- Peppol
- Registered · 0208:0827039024 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 25 Jun 2010
- Registered office
- 2222 Heist-op-den-Berg
- Latest accounts
- 2025 · filed on 28 Aug 2026
- Activity
- Activities of holding companies (NACE 64210)
Pharmasense (SRL) has been based in Heist-op-den-Berg since 2010, active in: activities of holding companies. For 2025, it reports a net profit of 157,945 € and equity of €1.26m; its revenue is not published. Its solvency stands at 65.1%, above the median of its sector (55.6%).
Companies similar to Pharmasense
Companies in the same business, of comparable size and area, outside its group.
- Geni@L Activities of holding companies Aubel · balance sheet €1.94m
- Meermar Activities of holding companies Hoogstraten · balance sheet €1.94m
- JDC Consultancy Activities of holding companies Kortrijk · balance sheet €1.94m
- Belisy Activities of holding companies Knokke-Heist · balance sheet €1.94m
- Renardmont Activities of holding companies Hasselt · balance sheet €1.92m
- Majale Activities of holding companies Knokke-Heist · balance sheet €1.94m
- K & G Invest Activities of holding companies Roeselare · balance sheet €1.94m
- Ozzy2Louis Invest Activities of holding companies Tremelo · balance sheet €1.91m
Frequently asked questions about Pharmasense
What is the revenue of Pharmasense?
Pharmasense files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Pharmasense?
In Belgium, the VAT number is the company number prefixed with BE: BE0827039024 for Pharmasense, if the company is VAT-registered. Its company number (CBE) is 0827.039.024.
Where is the registered office of Pharmasense?
According to the CBE register, the registered office of Pharmasense is in 2222 Heist-op-den-Berg.
What is the equity of Pharmasense?
At the close of the 2025 financial year, the equity of Pharmasense amounts to 1,255,532 €, a solvency of 65.1% of total assets.
Who manages Pharmasense?
The register lists 2 active mandates at Pharmasense. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Pharmasense
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →